Case Report: Self-Expanding Transcatheter Valve Implantation (Acurate Neo 2) in a Very Small Native Aortic Annulus
Source : https://www.frontiersin.org/articles/10.3389/fcvm.2023.1195486/full
Transcatheter aortic valve replacement (TAVR) is a treatment of choice in patients with symptomatic severe aortic valve stenosis (AS) and intermediate-to-high surgical risk. The presence of a small aortic annulus...
Transcatheter aortic valve replacement (TAVR) is a treatment of choice in patients with symptomatic severe aortic valve stenosis (AS) and intermediate-to-high surgical risk. The presence of a small aortic annulus (SAA) has been associated with a higher incidence of prosthesis–patient mismatch (PPM) when surgical aortic valve replacement...
Cardiac Catheterization, Coronary Intervention, and Wait Times for Transcatheter Aortic Valve Replacement
Source : https://pubmed.ncbi.nlm.nih.gov/37799044/
TAVR wait times were not affected by the COVID-19 pandemic or single rural TAVR center travel distance. Sicker patients were more likely to achieve STWT while catheterization/PCI before TAVR was...
TAVR wait times were not affected by the COVID-19 pandemic or single rural TAVR center travel distance. Sicker patients were more likely to achieve STWT while catheterization/PCI before TAVR was associated with longer wait times.
A Novel Score to Predict One-Year Mortality After Transcatheter Aortic Valve Replacement, Naples Prognostic Score
Source : https://pubmed.ncbi.nlm.nih.gov/37763785/
Background and Objectives : Aortic stenosis (AS) is a widespread valvular disease in developed countries, primarily among the elderly. Transcatheter aortic valve replacement (TAVR) has become a viable alternative to...
Our results show that NPS is an independent predictor of one-year mortality in patients undergoing TAVR.
Two-Year Outcomes of Valve-in-Valve Using New-Generation Transcatheter Devices Compared With Redo-SAVR
Source : https://pubmed.ncbi.nlm.nih.gov/37778227/
Few studies have compared the clinical outcomes between valve-in-valve transcatheter aortic valve replacement (ViV-TAVR) with new-generation valves and re-operative surgical aortic valve replacement (Redo-SAVR). We compared the clinical outcomes of...
The long-term outcomes of ViV-TAVR using new-generation valves were similar to those of Redo-SAVR, although ViV-TAVR was associated with lower rates of in-hospital complications.
An analysis regarding the article: Insight into the Optimal Timing of Percutaneous Coronary Intervention and Transcatheter Aortic Valve Replacement
Source : https://www.sciencedirect.com/science/article/abs/pii/S0146280623005248?via=ihub
Transcatheter aortic valve replacement (TAVR) is an emerging minimally invasive treatment modality that has been shown to reduce mortality significant...
The risk factors associated after TAVR include larger annulus size (based on MSCT), pre-TAVI transvalvular Vmax, aortic valve calcification; aortic valve calcification was found to be an independent predictor of PVL.